Surrey Heartlands

Joint Formulary & PAD

Vedolizumab - Pouchitis

You are here : Home > Formulary Search > Vedolizumab - Pouchitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Not Specified
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :
Important

This drug, for this indication, has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Vedolizumab
Indication :
Pouchitis
Group Name :
Keywords :
Brand Names Include :
Entyvio
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Vedolizumab is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pouchitis.

Committee Recommendations (1)

06 Jul 22 - Not Set

This drug / device has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands Area Prescribing Committee (APC). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined. It is recommended that clinicians contact their medicines management team for further information and advice before prescribing this drug.
The APC will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsccg.APC@nhs.net  if they wish to make a submission.